Skip to Content
Merck
CN
  • Synthesis and biological evaluation of a novel series of bis-salicylaldehydes as mushroom tyrosinase inhibitors.

Synthesis and biological evaluation of a novel series of bis-salicylaldehydes as mushroom tyrosinase inhibitors.

Bioorganic & medicinal chemistry letters (2010-09-04)
Giovanna Delogu, Gianni Podda, Marcella Corda, Maria Benedetta Fadda, Antonella Fais, Benedetta Era
ABSTRACT

A series of novel bis-salicylaldehydes were synthesised and evaluated as tyrosinase inhibitors using a tyrosinase-dependent L-DOPA oxidation assay. The bis-salicylaldehydes exhibited greater inhibitory activity than salicylaldehyde. Our data suggests that these novel compounds may serve as a structural template for the design and development of novel tyrosinase inhibitors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Salicylaldehyde, reagent grade, 98%
Supelco
Salicylaldehyde, analytical standard
Sigma-Aldrich
Salicylaldehyde, ≥98%, FG
Sigma-Aldrich
Kojic acid